| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.17 | 0.008 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.17 | 0.008 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |